Cancer metabolism: a therapeutic perspective

Cites (228)

Items 201–228 of 228

1. A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
   Carolyn D. Britten, Eric Keith Rowinsky, Sharyn D. Baker, Geoffrey R. Weiss, L Smith, Joseph Stephenson, Mace L. Rothenberg, Leslie Smetzer, Jeffrey A. Cramer, W Collins et al. · 2000 · PubMed
2. Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?
   Maria Peiris‐Pagès, Ubaldo Martinez‐Outschoorn, Federica Sotgia, Michael P. Lisanti · 2015 · Cell Metabolism
3. HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
   Talía Velasco-Hernández, Axel Hyrenius Wittsten, Matilda Rehn, David Bryder, Jörg Cammenga · 2014 · Blood
4. Ecology meets cancer biology: The cancer swamp promotes the lethal cancer phenotype
   Sarah R. Amend, Kenneth J. Pienta · 2015 · Oncotarget
5. Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer
   Elizabeth Pham, Michael J. Birrer, Scott D. Eliasof, Edward Graeme Garmey, Douglas D. Lazarus, Christina R. Lee, Shan Man, Ursula A. Matulonis, Christian G. Peters, Ping Xu et al. · 2014 · Clinical Cancer Research
6. Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
   Rob Pieters, Inge M. Appel, Hans Juergen Kuehnel, Iris Tetzlaff-Fohr, Uwe Pichlmeier, Inekee van der Vaart, Eline G. Visser, Rolinda L. Stigter · 2008 · Blood
7. Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment
   Matthew Lawrence Goodwin, Huifeng Jin, Krystal M. Straessler · 2014 · Cancer Cell
8. Arginine deprivation in cancer therapy
   Lynn G. Feun, Macus Tien Kuo, Niramol Savaraj · 2014 · Current Opinion in Clinical Nutrition & Metabolic Care
9. R-2-Hydroxyglutarate as the Key Effector of IDH Mutations Promoting Oncogenesis
   Dan Ye, Shenghong Ma, Yue Xiong, Kun‐Liang Guan · 2013 · Cancer Cell
10. Peptide and small molecule inhibitors of the Keap1–Nrf2 protein–protein interaction
    Geoffrey Wells · 2015 · Biochemical Society Transactions
11. Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide
    Paola Papaldo, Massimo Lopez, Enrico Cortesi, Eugenio Cammilluzzi, Mauro Antimi, Edmondo Terzoli, Giuseppe Lepidini, Patrizia Vici, Carlo Antonio Barone, Gianluigi Ferretti et al. · 2003 · Journal of Clinical Oncology
12. NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
    Emmanuel S. Burgos · 2011 · Current Medicinal Chemistry
13. A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling
    Brian F. Clem, Amy L. Clem, Abdullah Yalçın, U Goswami, Sengodagounder Arumugam, Sucheta Telang, John O. Trent, Jason Alan Chesney · 2011 · Oncogene
14. Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels
    Scott K. Parks, Nathalie M. Mazure, Laurent Counillon, Jacques Pouysségur · 2013 · Journal of Cellular Physiology
15. Involvement of human choline kinase alpha and beta in carcinogenesis: A different role in lipid metabolism and biological functions
    David Gallego‐Ortega, Teresa Gómez del Pulgar, Fátima Valdés‐Mora · 2010 · Advances in Enzyme Regulation
16. Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
    Gagan Deep, Rajesh Agarwal · 2013 · Current Cancer Drug Targets
17. Statins in oncological research: From experimental studies to clinical practice
    Peter Kubatka, Peter Kružliak, Vladimír Rotrekl · 2014 · Critical Reviews in Oncology/Hematology
18. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
    Rebecca Lamb, Béla Ózsvári, Gloria Bonuccelli, Duncan L. Smith, Richard G. Pestell, Ubaldo Martinez‐Outschoorn, Robert B. Clarke, Federica Sotgia, Michael P. Lisanti · 2015 · Oncotarget
19. Glucose and glutamine metabolism in oral squamous cell carcinoma: insight from a quantitative metabolomic approach
    Tamaki Ogawa, Jumpei Washio, Tetsu Takahashi, Seishi Echigo, Nobuhiro Takahashi · 2014 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
20. Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity
    José Antonio Jara, Rodrigo López‐Muñoz · 2015 · Pharmacological Research
21. Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia
    Amir T. Fathi, Seth Andrew Wander, Rawan G. Faramand, Ashkan Emadi · 2015 · Seminars in Hematology
22. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery
    Meghna Talekar, Srinivas Reddy Boreddy, Amit Singh, Mansoor M. Amiji · 2014 · Expert Opinion on Biological Therapy
23. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
    Katarína Smolková, Aleš Dvořák, Jaroslav Zelenka, Libor Vı́tek, Petr Ježek · 2015 · The International Journal of Biochemistry & Cell Biology
24. Cloning, Expression, Activity and Folding Studies of Serine Hydroxymethyltransferase: A Target Enzyme for Cancer Chemotherapy
    Shipra Agrawal, Ajay Kumar, Vivek Kumar Srivastava, Bhartendu Nath Mishra · 2003 · Microbial Physiology
25. Metabolic control of epilepsy
    Helen E. Scharfman · 2015 · Science
26. Metabolism and cancer
    Albert Szent‐Györgyi · 2009 · International Journal of Quantum Chemistry
27. The Advantages of Togetherness
    Edward C. Cox, John Tyler Bonner · 2001 · Science
28. Mitoribosome oddities
    Roland Beckmann, Johannes M. Herrmann · 2015 · Science